BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12014707)

  • 1. A strategy for identifying osteoporosis risk genes.
    Rowe D; Lichtler A
    Endocrine; 2002 Feb; 17(1):67-75. PubMed ID: 12014707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A microarray based identification of osteoporosis-related genes in primary culture of human osteoblasts.
    Trost Z; Trebse R; Prezelj J; Komadina R; Logar DB; Marc J
    Bone; 2010 Jan; 46(1):72-80. PubMed ID: 19781675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress in understanding the genetic susceptibility to osteoporosis.
    Zmuda JM; Cauley JA; Ferrell RE
    Genet Epidemiol; 1999; 16(4):356-67. PubMed ID: 10207717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteogenic differentiation of recombinant adeno-associated virus 2-transduced murine mesenchymal stem cells and development of an immunocompetent mouse model for ex vivo osteoporosis gene therapy.
    Kumar S; Mahendra G; Nagy TR; Ponnazhagan S
    Hum Gene Ther; 2004 Dec; 15(12):1197-206. PubMed ID: 15684696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SWI/SNF-Mediated Lineage Determination in Mesenchymal Stem Cells Confers Resistance to Osteoporosis.
    Nguyen KH; Xu F; Flowers S; Williams EA; Fritton JC; Moran E
    Stem Cells; 2015 Oct; 33(10):3028-38. PubMed ID: 26059320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profile induced by ovariectomy in bone marrow of mice: a functional approach to identify new candidate genes associated to osteoporosis risk in women.
    Pineda B; Serna E; Laguna-Fernández A; Noguera I; Panach L; Hermenegildo C; Tarín JJ; Cano A; García-Pérez MÁ
    Bone; 2014 Aug; 65():33-41. PubMed ID: 24815918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis: A Silent Disease with Complex Genetic Contribution.
    Mafi Golchin M; Heidari L; Ghaderian SM; Akhavan-Niaki H
    J Genet Genomics; 2016 Feb; 43(2):49-61. PubMed ID: 26924688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Approaches To Identifying Novel Osteoporosis Drug Targets.
    Brommage R
    J Cell Biochem; 2015 Oct; 116(10):2139-45. PubMed ID: 25833316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of osteoporosis.
    Peacock M; Turner CH; Econs MJ; Foroud T
    Endocr Rev; 2002 Jun; 23(3):303-26. PubMed ID: 12050122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic control of susceptibility to osteoporosis.
    Ralston SH
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2460-6. PubMed ID: 12050200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic epidemiological approaches to the search for osteoporosis genes.
    Nguyen TV; Blangero J; Eisman JA
    J Bone Miner Res; 2000 Mar; 15(3):392-401. PubMed ID: 10750553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissection of the sets of genes that control the behavior of biglycan-deficient pre-osteoblasts using oligonucleotide microarrays.
    Chen XD; Bian X; Teslovich TM; Stephan DA; Young MF
    Bone; 2005 Aug; 37(2):192-203. PubMed ID: 15922682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous fractures in the mouse mutant sfx are caused by deletion of the gulonolactone oxidase gene, causing vitamin C deficiency.
    Mohan S; Kapoor A; Singgih A; Zhang Z; Taylor T; Yu H; Chadwick RB; Chung YS; Donahue LR; Rosen C; Crawford GC; Wergedal J; Baylink DJ
    J Bone Miner Res; 2005 Sep; 20(9):1597-610. PubMed ID: 16059632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying genetic risk factors for osteoporosis.
    Uitterlinden AG; van Meurs JB; Rivadeneira F; Pols HA
    J Musculoskelet Neuronal Interact; 2006; 6(1):16-26. PubMed ID: 16675886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atm-deficient mice: an osteoporosis model with defective osteoblast differentiation and increased osteoclastogenesis.
    Rasheed N; Wang X; Niu QT; Yeh J; Li B
    Hum Mol Genet; 2006 Jun; 15(12):1938-48. PubMed ID: 16644862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of osteoporosis.
    Ralston SH; Uitterlinden AG
    Endocr Rev; 2010 Oct; 31(5):629-62. PubMed ID: 20431112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic Mesenchymal Stem Cell Therapy Promotes Osteoblastogenesis and Prevents Glucocorticoid-Induced Osteoporosis.
    Sui B; Hu C; Zhang X; Zhao P; He T; Zhou C; Qiu X; Chen N; Zhao X; Jin Y
    Stem Cells Transl Med; 2016 Sep; 5(9):1238-46. PubMed ID: 27365487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of osteoporosis.
    Ralston SH
    Ann N Y Acad Sci; 2010 Mar; 1192():181-9. PubMed ID: 20392235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of osteoporosis.
    Eisman JA
    Endocr Rev; 1999 Dec; 20(6):788-804. PubMed ID: 10605626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression analysis in human osteoblasts exposed to dexamethasone identifies altered developmental pathways as putative drivers of osteoporosis.
    Hurson CJ; Butler JS; Keating DT; Murray DW; Sadlier DM; O'Byrne JM; Doran PP
    BMC Musculoskelet Disord; 2007 Feb; 8():12. PubMed ID: 17295923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.